# Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers

> **NCT02992236** · PHASE1 · COMPLETED · sponsor: **veriNOS operations GmbH** · enrollment: 16 (actual)

## Conditions studied

- Renal Function Impairment in Healthy Volunteers

## Interventions

- **DRUG:** VAS203
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02992236
- **Lead sponsor:** veriNOS operations GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2016-05
- **Final completion:** 2016-11
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02992236

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02992236, "Effects of the NO-synthase Inhibitor VAS203 on Renal Function in Healthy Volunteers". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02992236. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*